Department of Pathology News

Repairing nerve cell damage from multiple sclerosis

Tuesday, June 17, 2014

Dr. Bridget-Shafit Zagardo investigates how to repair nerve cell damage from multiple sclerosis.

Each year multiple sclerosis (MS) strikes millions of young adults in the United States and worldwide, limiting their mobility, causing disability and pain, and seriously affecting their quality of life. Onset is observed in young adults in their 20's and 30's, with a pediatric form of MS becoming increasingly prevalent. While various current treatments delay progression or manage the symptoms, there is currently no cure and there is significant decline over a 15-20 year period with a large number of patients progressing from a relapsing remitting disease course to a progressive disease course.

For over 30 years, Einstein Pathology researcher Bridget Shafit-Zagardo, PhD, has worked to understand MS and give people suffering from the neurological disease hope.

“We’re predominantly interested in enhancing repair and functional recovery following central nervous system (CNS) injury,” said Dr. Shafit-Zagardo, a professor of pathology, who joined Einstein in 1984.

Enhancing repair

She explained that MS damages neurons, or nerve cells, and the myelin sheath - the insulation that surrounds and protects axons. The loss of myelin – demyelination - interferes with the transmission of normal nerve conductance required for nerves to signal between the brain, spinal cord and the rest of the body. 

“The goal is to repair axonal damage and enhance remyelination,” she said, noting that the current treatments address inflammation, but do not address nerve cell repair.

The exact antigen — or target that the immune cells are sensitized to attack — remains unknown, which is why MS is considered by many experts to be "immune-mediated," she said.

Abnormally hyper-activated infiltrating immune cells cross the blood brain barrier and induce inflammation in the CNS. As a result, resident cells of the CNS become activated and secrete inflammatory molecules that further enhance inflammation resulting in damage to neurons and oligodendrocytes, the myelin-synthesizing cells of the CNS. Axonal damage, destruction of myelin and activation of astrocytes called astrogliosis, ultimately result in CNS lesions referred to as glial scars or plaques in areas of damage. The resulting insult affects nerve fibers producing symptoms that may affect vision, coordination and mobility, and continence, among other symptoms.  

To that end, Dr. Shafit-Zagardo and her team are investigating strategies to slow the progression of axonal damage and demyelination and to enhance remyelination.

“Until damaged myelin and cell debris resulting from inflammation are cleared, you do not have efficient repair and recovery cannot occur,” said Dr. Shafit-Zagardo. The lab’s ongoing projects include applying techniques of molecular & cell biology, biochemistry, immunocytochemistry, confocal and electron microscopy to address questions concerning the structure, function and regulation of myelination in the normal CNS and remyelination following neuroimmune injury.

Identifying signaling pathways

Central to the treatment of MS is how cell signaling pathways regulate oligodendrocyte cell survival and remyelination after the inflammatory response.
Toward this goal, the lab has used molecular approaches to identify several genes implicated in signaling pathways that regulate oligodendrocytes and protect against demyelination. Among those genes identified were members of the Tyro3/Axl/Mer (TAM) family of receptor tyrosine kinases. As Dr. Shafit-Zagardo explained, to clear debris in MS lesions, the ligand or growth factor binds to receptors on the cell and signals downstream, recruiting signaling molecules that are protective for survival of the cell and also serve to activate other signaling pathways necessary for repair. The lab has demonstrated that signaling through the growth arrest-specific protein 6 (Gas6)/TAM pathway protects oligodendrocytes against injury.

Dr. Shafit-Zagardo’s research is funded by grants from the National Multiple Sclerosis Society and the National Institute of Neurological Disorders and Stroke. Assisting Dr. Shafit-Zagardo in her research is postdoctoral fellow Ross Gruber, graduate student Alex Ray and technician Kathleen O’Guin. Ross and Alex have been generating different mouse models, including single and double knockout mice that can be used to study different signaling pathways.

Moving forward

Despite her many achievements both inside and outside of science, the Bronx native has not had to venture far. After earning her master’s degree in biology at New York University, she studied human genetics with Dr. Robert Desnick and was awarded a PhD from City University of New York/ Mount Sinai School of Medicine, where her research focused on lysosomal storage diseases focusing on Gaucher’s disease. She initially joined Einstein as a postdoctoral research fellow under the mentorship of Dr. Joseph Maio in Cell Biology, working on long interspersed repetitive sequences. Dr. Shafit-Zagardo became involved in MS after seeing that early developmental genes could be turned back on during remyelination, and continued to expand on those initial studies.

MS research has come a long way in the last two decades. “Thirty years ago, there were no real treatments,” Dr. Shafit-Zagardo said, noting that the last 20 years has seen a variety of medications used for MS to block inflammation, but they do not target myelin repair.

Moving forward, her lab will continue to work toward developing better treatment and attempt to attempt to find factors that can aid in repair. She said, “Once we’ve determined how signaling occurs we will be able to use this information to protect against further damage."


Recent News

tomitaReeling in the Structure of a Ubiquitous Parasite 
Postdoctoral researcher Tadakimi Tomita was raised on a mushroom farm in Japan; his love for nature inspired his research and passion for science. Working in the laboratory of Dr. Louis Weiss, Dr. Tomita discovered and characterized a novel glycoprotein responsible for structural integrity of the Toxoplasma gondii cell wall.  

Veenstra On Science, Life, and Love in New York City
Mike Veenstra, a Dutch PhD student in Dr. Joan Berman's lab, was interviewed last month by Oost TV as part of a series on people from the Overijssel region of the Netherlands who currently work and live in New York City. In this series, Mike discusses (in Dutch) his science, life in NYC - and what first brought him to the United States. Although the interview was conducted in Dutch - without subtitles - we’ve loosely summarized the video. Please take a look here.

Michael PrystowskySee Test & Treat: Free Cancer Screenings for Underserved Women
A team of Montefiore pathologists and clinicians from the departments of Obstetrics & Gynecology and Radiology provided free cervical and breast cancer screenings recently to over 40 underserved women ages 21 to 64 at the annual See Test & Treat® program, held at Montefiore Advanced Imaging, part of the Moses Division of Montefiore Medical Center in the Bronx.

Michael PrystowskyInspiring the Next Generation of Pathologists
The Pathologist magazine interviews Dr. Michael Prystowsky about his career, heading up one of the busiest pathology services in the US, and how pathologists can demonstrate their value.

Tiffany HebertMontefiore Pathologist Focuses on Training to Improve Testing Access in Rwanda.
Podcast: The College of American Pathologists (CAP) interviews Dr. Tiffany Hebert on her experience training a Rwandan physician to perform pathology testing services as part of a comprehensive program to improve screening methods and reduce the number of Rwandan women who die from HIV-related cancers.

research fundingPathology Research Funding Program
The Department of Pathology has established a funding program to encourage residents and fellows to participate in clinical pilot research projects. Up to $2,000 will be awarded per research project, for projects of up to two years in duration. The newly-formed Clinical-Translational Research Committee will assist in the review of proposals, which may be submitted two times per year.

laura65Aging-related Changes Detected in Lymph Vessels
Einstein scientist have explained for the first time how aging affects lymph vessels and the flow of lymph in the body. Findings expected to be published in May issue of Aging Cell.

Levi 65A Faster Approach to Identifying Bacteria
The Montefiore microbiology lab is using MALDI-TOF mass spectometry, an innovative technology that can identify bacteria in minutes.

Jyothi NagajyothiJyothi Nagajyothi, PhD, Awarded RO1 Grant from NIH National Heart, Lung and Blood Institute
Dr. Jyothi Nagajyothi will further her research program investigating the link between Chagas disease and metabolic disorders.

CadoffThe Department of Pathology Welcomes Dr. Evan Cadoff, New Vice Chair
Evan Cadoff, MD, MBA will manage the reorganization of Montefiore’s laboratory services and facilitate the expansion of programs.

Dr. Carol Harris breast cancer prevention Ethiopia albert einstein college of medicine montefiore medical center bronx nyBattling Breast Cancer in Ethiopia
Dr. Carol Harris's work with local caregivers & leaders is addressing Ethiopia's growing breast cancer rates.

Maja Oktay, MD, PhD, albert einstein college of medicine montefiore medical center bronx nyNew Insights into Breast Cancer Spread Could Yield Better Tests and Treatments
A new study provides compelling evidence that a specific trio of cells is required for the spread of breast cancer. The study was published in Science Signaling

Bridget Shafit-Zagardo, PhD, albert einstein college of medicine bronx nyRepairing nerve cell damage from multiple sclerosis"
For over 30 years, Einstein Pathology researcher Bridget Shafit-Zagardo, PhD, has worked to understand MS and give people suffering from the neurological disease hope.

Tanowitz, albert einstein college of medicine bronx nyCUNY-TV Interviews Dr. Herbert Tanowitz
CUNY-TV interviews Dr. Herbert Tanowitz on the rising spread of infectious diseases to non-endemic areas. Dr. Tanowitz is professor in the departments of pathology and of medicine (infectious diseases). His laboratory investigates the pathogenesis of chagastic heart disease, caused by the parasite Trypanosoma cruzi.  )Interview starts at minute 3:30)

Advancing NeuroAIDS Research

Einstein Graduate Dionna Williams, PhD, is heading to Johns Hopkins for a postdoctoral fellowship to further investigate NeuroAIDS. Full story 



Experimental pathology aims to define disease in terms of fundamental molecular and cellular processes. Research in our Department is focused on critical issues in multiple disease classes. Areas of focus include 

Research in each of these areas is highly interactive, and the Department strives for a collegial atmosphere in which collaborations can flourish. This effort is conducted through a variety of department-level activities, including regular meetings to discuss work in progress and a departmental retreat at which students, postdoctoral fellows, residents and faculty all have opportunity to present and discuss their research.

Research Funding Program

The Department of Pathology has established a research funding program to encourage residents and fellows to participate in clinical pilot research projects. Up to $2,000 will be awarded per research project, for projects of up to two years in duration.

Research Faculty

Thomas Belbin, PhD 

Joan W. Berman, PhD 

Tina Calderon, PhD 

Linda Cannizzaro, PhD 

Mahalia Desruisseaux, MD, PhD 

Amy Fox, MD  

David Fooksman, PhD  

Rachel Hazan, PhD 

Huan Huang, MD 

Fernando Macian, MD, PhD 

Maja Oktay, MD, PhD 

Harry Ostrer, MD 

Thomas J. Ow, MD 

Michael B. Prystowsky, MD, PhD 

Moshe Sadofsky, MD, PhD 

Laura Santambrogio, MD, PhD 

Rani Sellers, DVM, PhD 

Bridget Shafit-Zagardo, PhD 

Herbert Tanowitz, MD 

Louis Weiss, MD 

Click here to log in